C O M M U N I C A T I O N S
Scheme 2. Completion of the Synthesisa
a Conditons: (a) Ac2O, Py, 93%; (b) DDQ, CH2Cl2/pH 7 buffer, 79%; (c) Phenyl 2,3,4,6-tetra-O-benzyl-1-thio-â-D-glucopyranoside S-oxide, Tf2O, DTBMP,
ADMB, propionitrile, -78 °C, 76%; (d) NH3 in IPA/ CH2Cl2; (e) ethylenediamine, EtOH, 60 °C; (f) Ac2O, EtOH; (g) Ac2O, Py, 66% four steps; (h) H2,
Pd(OH)2/C, MeOH; (i) Ac2O, Py, 63% two steps; (j) BF3·Et2O, CH2Cl2, 97%; (k) 2-amino-3-hydroxy-2-cyclopenten-1-one hydrochloride, HATU, DIPEA,
CH2Cl2/DMF, 55%; (l) NaOH, THF, 80%; (m) Ac2O, Py, 78%; (n) H2NNH2·HOAc, 75%; (1) 2-Chloro-1,3,2-benzodioxaphosphorin-4-one, CH3CN, 85%;
(2) Py, 4 Å MS, methyl (R)-3-hydroxy-2-[(2Z,6E,13E)-3,8,8,14,18-pentamethyl-11-methylene-nonadeca-2,6,13,17-tetraen-1-yloxy]propanoate, 1-adaman-
tanecarbonyl chloride, then NMM/CCl4/Py/CH3CN/H2O (1:2.5:6:1:1), 62%; (3) 0.1 N LiOH, THF/H2O (1:1), then AcOH, 47%.18
when donor 7 was added to a solution containing triflic anhydride
and acceptor 9, tetrasaccharide 10 was obtained stereoselectively
in 50% yield. The free hydroxyl on the C ring was then acetylated
followed by removal of the PMB ether with DDQ to give 11
(Scheme 2).
previously,19 should enable the construction of most glycosidic
linkages.
Acknowledgment. Support for this work was provided by the
National Institutes of Health (Grant GM66174).
The final glycosylation involved forming a â-1,6 linkage between
a D ring sulfoxide and tetrasaccharide 11. To avoid introducing a
hindered, electron-withdrawing ester group on the C2 position of
the D ring donor, we chose to form this glycosidic linkage with
solvent control using propionitrile, which is known to give high
â-stereoselectivity in glycosylations.9,15 As before, benzenesulfinic
ester byproducts dominated the reaction in the absence of a PhSOTf
scavenger. When the reaction was carried out using the scavenger
ADMB and inverse addition, pentasaccharide 12 was obtained in
76% yield with complete â-stereoselectivity.
Supporting Information Available: Experimental procedures and
spectral data for numbered compounds. This material is available free
References
(1) van Heijenoort, J. Glycobiology 2001, 11, 25R-36R and references
therein.
(2) For a review of previous synthetic efforts toward moenomycin A see
Welzel, P. Chem. ReV. 2005, 105, 4610-4660.
(3) Mu¨ller, T.; Schneider, R.; Schmidt, R. R. Tetrahedron Lett. 1994, 35,
4763-4766.
Completion of the moenomycin pentasaccharide synthesis re-
quired protecting group removal and installation of the 2-amino-
3-hydroxy-2-cyclopenten-1-one (A ring) chromophore and F ring
amide and carbamate. Selective conversion of the phenyl ester and
phenyl carbonate of 12 into the desired carboxamide and carbamate,
respectively, was accomplished using NH3 in IPA/CH2Cl2. The TCP
protecting groups were then removed with ethylenediamine and
the liberated amines were acylated in situ to give 13. Hydrogenation
of the benzyl groups using Pd(OH)2/C in MeOH and acetylation
of the hydroxyls gave 14. Removal of the TMSE groups with BF3,16
followed by coupling of the A ring17 using HATU, and global
deprotection with NaOH afforded the fully deprotected penta-
saccharide 15. The identity of 15 was confirmed by correlation with
the natural pentasaccharide obtained through degradation of moeno-
mycin A. Peracetylation of 15 followed by selective deprotection
of the anomeric acetate with H2NNH2·HOAc gave 16. Coupling of
16 to the moenocinyl glycerate unit and deprotection, using our
published procedure,18 afforded moenomycin A (1).
(4) (a) Paulsen, H. Angew. Chem., Int. Ed. Engl. 1982, 21, 155-173. (b)
Crich, D.; Dudkin, V. J. Am. Chem. Soc. 2001, 123, 6819-6825.
(5) Welzel, P.; Kunisch, F.; Kruggel, F.; Stein, H.; Scherkenbeck, J.; Hiltmann,
A.; Duddeck, H.; Mu¨ller, D.; Maggio, J. E.; Fehlhaber, H. W.; Seibert,
G.; van Heijenoort, Y.; van Heijenoort, J. Tetrahedron 1987, 43, 585-
598.
(6) Marzian, S.; Happel, M.; Wagner, U.; Mu¨ller, D.; Welzel, P.; Fehlhaber,
H. W.; Sta¨rk, A.; Schu¨tz, H. J.; Markus, A.; Limbert, M.; van Heijenoort,
Y.; van Heijenoort, J. Tetrahedron 1994, 50, 5299-5308.
(7) (a) Debenham, J. S.; Madsen, R.; Roberts, C.; Fraser-Reid, B. J. Am. Chem.
Soc. 1995, 117, 3302-3303. (b) Castro-Palomino, J. C.; Schmidt, R. R.
Tetrahedron Lett. 1995, 36, 5343-5346.
(8) (a) Lay, L.; Manzoni, L.; Schmidt, R. R. Carbohyd. Res. 1998, 310, 157-
171. (b) Ellervik, U.; Magnusson, G. J. Org. Chem. 1998, 63, 9314-
9322.
(9) Kahne, D.; Walker, S.; Cheng, Y.; Van Engen, D. J. Am. Chem. Soc.
1989, 111, 6881-6882.
(10) For a discussion of benzenesulfinic ester formation see Taylor, J. G. Ph.D.
Thesis, Harvard University, 2006.
(11) Crich, D.; Sun, S. J. Am. Chem. Soc. 1997, 119, 11217-11223.
(12) Gildersleeve, J.; Smith, A.; Sakurai, K.; Raghavan, S.; Kahne, D. J. Am.
Chem. Soc. 1999, 121, 6176-6182.
(13) Gildersleeve, J.; Pascal, R. A. J.; Kahne, D. J. Am. Chem. Soc. 1998,
120, 5961-5969.
(14) Herna´ndez-Torres, J. M.; Achkar, J.; Wei, A. J. Org. Chem. 2004, 69,
7206-7211.
(15) Schmidt, R. R.; Behrendt, M.; Toepfer, A. Synlett 1990, 11, 694-
This synthesis of moenomycin A is both efficient and flexible,
allowing for variants of the antibiotic to be constructed in order to
probe its mechanism of action. Each glycosidic linkage was
synthesized stereoselectively using the sulfoxide glycosylation
reaction. Two sets of reaction conditions were employed depending
on the reactivity of the donor-acceptor pair. The sulfoxide
activation conditions described here, along with those described
696.
(16) Jansson, K.; Ahlfors, S.; Frejd, T.; Kihlberg, J.; Magnusson, G.; Dahme´n,
J.; Noori, G.; Stenvall, K. J. Org. Chem. 1988, 53, 5629-5647.
(17) Ebenezer, W. J. Synth. Commun. 1991, 21, 351-358.
(18) Adachi, M.; Zhang, Y.; Leimkuhler, C.; Sun, B.; LaTour, J., Kahne, D.
D. J. Am. Chem. Soc. 2006, 128, 14012-14013.
(19) Crich, D.; Lim, L. B. L. Org. React. 2004, 64, 115-251.
JA065907X
9
J. AM. CHEM. SOC. VOL. 128, NO. 47, 2006 15085